Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Recruiting · NCT06006650 · Registry updated 2023-08-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2023-08-23 | NCT06006650 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tang-Du Hospital | 93 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hongtao Duan | Xi’an | China | 1 |
| Tangdu Hospital of the Fourth Millitary Medical University | Xi'an | China | 1 |
| Tangdu Hospital, the Air Force Military University | Xi'an | China | 2 |